JOBEVNE Q Code: Q5160

Drug & Product Overview

HCPCS Descriptor Injection, bevacizumab-nwgd (jobevne), biosimilar, 10 mg

HCPCS Added Date January 1, 2026

Manufacturer Biocon Biologics

Route of Administration Intravascular

Generic Status Single-Source; Branded

Dosage Type Single-Dose

Dosage Form Injection

About JOBEVNE

Jobevne is a medication aligned to the HCPCS Q Code: Q5160 for billing, pricing, and reimbursement purposes in the United States. It is an Oncology drug administered via the intravascular route and manufactured by Biocon Biologics.

According to CMS Drug Use Information: This medication is a man-made antibody (IgG1) used to treat various types of cancer. This drug works by blocking a certain protein (vascular endothelial growth factor-VEGF) thereby decreasing the blood supply to the tumor and slowing tumor growth. This monograph is about the following bevacizumab products: bevacizumab, bevacizumab-adcd, bevacizumab-awwb, bevacizumab-bvzr, bevacizumab-maly, and bevacizumab-nwgd.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
83257-0009-11	Jobevne	Biocon Biologics Inc.	10	100 MG / 4 ML
83257-0010-11	Jobevne	Biocon Biologics Inc.	40	400 MG / 16 ML

Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

JOBEVNE Pricing & Reimbursement

Q5160 Private Payer Reimbursement

$82.10 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q4 2026

Bevacizumab Biosimilar Information:

JOBEVNE Approval Date: April 9, 2025

Product Name	HCPCS Code	Active Ingredient	BLA Type
Avastin	J9035	Bevacizumab	351(a) Originator Product
Avzivi	N/A	Bevacizumab	351(k) Biosimilar
Mvasi	Q5107	Bevacizumab	351(k) Biosimilar
Zirabev	Q5118	Bevacizumab	351(k) Biosimilar
Alymsys	Q5126	Bevacizumab	351(k) Biosimilar
Vegzelma	Q5129	Bevacizumab	351(k) Biosimilar
Jobevne	Q5160	Bevacizumab	351(k) Biosimilar

JOBEVNE CPT Administration Codes

CPT Code	Description
96413	Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415	Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)

Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

JOBEVNE Medically Unlikely Edits (MUE)

The most billing units of Q5160 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 10 mg.

Practitioner Office & Hospital Outpatient

230 units / day

= 2,300 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

JOBEVNE Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Metastatic Colorectal Cancer Metastatic Renal Cell Carcinoma Non-Squamous Non-Small Cell Lung Cancer Persistent, Recurrent, or Metastatic Cervical Cancer Recurrent Glioblastoma

Drug Class

Vascular Endothelial Growth Factor Inhibitor [EPC]Vascular Endothelial Growth Factor Inhibitors [MoA]Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]

Frequently Asked Questions

Is there a manufacturer-published JOBEVNE billing and coding guide?

Billing and coding information for JOBEVNE can be found through Biocon Biologics Inc.. Visit Here →

Is there an available JOBEVNE patient assistance program?

JOBEVNE patient assistance information can be found through Biocon Biologics Inc.. Visit Here →

Where can I find JOBEVNE prescribing information?

JOBEVNE prescribing information can be found at the link below. Visit Here →

Where can I find JOBEVNE side effect information?

JOBEVNE side effect information can be found through MedlinePlus. Visit Here →

Does billing JOBEVNE require JZ/JW wastage modifiers?

CMS does not include JOBEVNE (Q5160) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing Q5160. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.